Differential baseline and response profile to IFN-γ gene transduction of IL-6/IL-6 receptor-α secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Chou, Andy Shau Bin ^a,d   Wang, Hsin Yi ^a   Chen, Hung Chang ^a   Tsai, Ming Hsiu ^b   Chuang, Cheng Keng ^c   Liao, Shuen Kuei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; RETROVIRUS VECTOR; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN-6 RECEPTOR ALPHA;

ANTIGEN DETECTION; ARTICLE; ASCITES; BONE MARROW METASTASIS; CANCER CELL CULTURE; CELL CLONE; CELL KINETICS; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC STABILITY; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIMARY TUMOR; VIRAL GENE DELIVERY SYSTEM; BONE MARROW CANCER; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METASTASIS; NASOPHARYNX TUMOR; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SECRETION; TUMOR CELL CULTURE; TUMOR CELL LINE;

BONE MARROW NEOPLASMS; CELL LINE, TUMOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; NASOPHARYNGEAL NEOPLASMS; PHENOTYPE; RECEPTORS, INTERLEUKIN-6; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 67650090386     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-169     Document Type: Article

References (49)

1. Borden EC Wit PL Paulnock S Grossberg S Antitumor effects of interferons: Mechanisms and therapeutic activity Biological Approaches to Cancer Treatment Modulation. McGraw-Hill: New York Michell MS 1993:440-476
2. Gansbacher B Rosenthal FM Zier K Retroviral vector-mediated cytokine-gene transfer into tumor cells Cancer Invest 1993, 11:345-354 10.3109/07357909309024862 8485657
3. Abdel-Wahab ZA Osanto S Darrow TL Barber JR Vervaert CE Gangavalli R McCallister TJ Seigler HF Transduction of human melanoma cells with the γ-interferon gene enhances cellular immunity Cancer Gene Ther 1994, 1:171-179 7621248
4. Nayak SK McCallister T Han LJ Gangavalli R Barber J Dillman RO Transduction of human renal carcinoma cells with human γ-interferon gene via retroviral vector Cancer Gene Ther 1996, 3:143-150 8725877
5. Howard B Burranscano M McCallister T Retroviral mediated gene transfer of human γ-IFN genes: A therapy for cancer Gene Therapy for Neoplastic Diseases New York Acad Sci: New York 1994
6. Boon T Coulie PG Eynde Van den B Tumor antigens recognized by T cells Immunol Today 1997, 18:267-268 10.1016/S0167-5699(97)80020-5 9190110
7. Novellino L Castelli C Parmiani G A listing of human tumor antigens recognized by T cells: March 2004 update Cancer Immunol Immunother 2005, 54:187-207 10.1007/s00262-004-0560-6 15309328
8. Gouttefangeas C Stenzl A Stevanovic S Rammensee HG Immunotherapy of renal cell carcinoma Cancer Immunol Immunother 2007, 56:117-128 10.1007/ s00262-006-0172-4 16676181
9. Pathmanathan R Prasad U Chandrika G Sadler R Flynn K Raab-Traub N Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia Am J Pathol 1995, 146:1355-1367 1870892 7778675
10. Fandi A Altun M Azli N Armand JP Cvitkovic E Nasopharyngeal cancer: epidemiology, staging, and treatment Semin Oncol 1994, 21:382-397 8209270
11. Zhang S Wu Y Zeng Y Zech L Klein G Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma Hereditas 1982, 97:23-28 10.1111/j.1601-5223.1982.tb00706.x 7129938
12. Lin C-T Wong C-I Chan W-Y Tzung K-W Ho J-K Hsu M-M Chuang S-M Establishment and characterization of two nasopharyngeal carcinoma cell lines Lab Invest 1990, 62:713-724 2162997
13. Huang D-P Ho J-H Poon Y-F Chew E-C Saw D Lui M Li CL Mak L-S Lai S-H Lau W-H Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx Int J Cancer 1980, 26:127-132 10.1002/ijc.2910260202 6259064
14. Glaser R Zhang HY Yao KT Zhu HC Wang FX Li GY Wen DS Li YP Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas Proc Natl Acad Sci USA 1989, 86:9524-9528 298529 2556716 10.1073/ pnas.86.23.9524
15. Liao S-K Perng Y-P Shen Y-C Chung P-J Chang Y-S Wang C-H Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion Cancer Genet Cytogenet 1998, 103:52-58 10.1016/S0165-4608(97)00416-0 9595045
16. Zen H-G Jame JM Chang A-Y Li W-Y Law C-K Chen K-Y Lin C-Z Nasopharyngeal carcinoma with bone marrow metastasis Am J Clin Oncol 1991, 14:66-70 10.1097/00000421-199102000-00015 1987743
17. Mansi JL Berger U McDonnell T Pople A Rayter Z Gazet JC Coombes RC The fate of bone marrow micrometastases in patients with primary breast cancer J Clin Oncol 1989, 7:445-449 2926469
18. Micheau C Boussen H Klijanienko J Cvitkovic E Stosic S Schwaab G Eschwege F Armand JP Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type Cancer 1987, 60:2459-2464 10.1002/ 1097-0142(19871115)60:10<2459::AID-CNCR2820601019>3.0.CO;2-0 3664429
19. Braun S Pantel K Micrometastatic bone marrow involvement: Detection and prognostic significance Med Oncol 1999, 16:154-165 10.1007/BF02906127 10523795
20. Putz E Witter K Offner S Stosiek P Zippelius A Johnson J Zahn R Riethmuller G Pantel K Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases Cancer Res 1999, 59:241-248 9892213
21. Chiu C-C Lin C-Y Lee L-Y Chen Y-J Kuo T-F Chang J-T Liao C-T Wang H-M Yen T-C Shen C-R Liao S-K et al Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention Mol Cancer Ther 2008, 7:2788-2797 10.1158/1535-7163.MCT-08-0172 18790759
22. Liao S-K Perng Y-P Lee L-A Chang KSS Lai G-M Wong E Ho Y-S Newly established MST-1 tumour cell line and tumour-infiltrating lymphocyte culture from a patient with soft tissue melanoma (clear cell sarcoma) and their potential applications to patient immunotherapy Eur J Cancer 1996, 32A:346-356 10.1016/0959-8049(95)00583-8 8664053
23. Hirano T Yasukawa K Harada H Taga T Watanabe Y Matsuda T Kashiwamura S Nakajima K Koyama K Iwamatsu A Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin Nature 1986, 324:73-76 10.1038/324073a0 3491322
24. Barton BE IL-6: Insights into novel biological activities Clin Immunol Immunopathol 1997, 85:16-20 10.1006/clin.1997.4420 9325064
25. Kishimoto T The biology of interleukin-6 Blood 1989, 74:1-10 2473791
26. Lu C Sheehan C Rak JW Chambers CA Hozumi N Kerbel RS Endogenous interleukin 6 can function as an in vivo growth-stimulatory factor for advanced-stage human melanoma cells Clin Cancer Res 1996, 2:1417-1425 9816316
27. Woods KV El-Naggar A Clayman GL Grimm EA Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens Cancer Res 1998, 58:3132-3141 9679981
28. Sansone P Storci G Tavolari S Guarnieri T Giovannini C Taffurelli M Ceccarelli C Santini D Paterini P Marcu KB et al IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J Clin Invest 2007, 117:3988-4002 2096439 18060036 10.1172/ JCI32533
29. Thiounn N Pages F Flam T Tartour E Mosseri V Zerbib M Beuzeboc P Deneux L Fridman WH Debre B IL-6 is a survival prognostic factor in renal cell carcinoma Immunol Lett 1997, 58:121-124 10.1016/S0165-2478(97)00036-9 9271323
30. Revel M Katz A Eisenbach L Feldman M Haran-Ghera N Harroch S Chebath J Interleukin-6: Effects on tumor models in mice and on the cellular regulation of transcription factor IRF-1 Ann N Y Acad Sci 1995, 762:342-355 7545371
31. Rabinovich A Medina L Piura B Segal S Huleihel M Regulation of ovarian carcinoma SKOV-3 cell proliferation and secretion of MMPs by autocrine IL-6 Anticancer Res 2007, 27:267-272 17352242
32. Porgador A Tzehoval E Katz A Vadai E Revel M Feldman M Eisenbach L Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells Cancer Res 1992, 52:3679-3686 1617640
33. Mackiewicz A Wiznerowicz M Roeb E Nowak J Pawlowski T Baumann H Heinrich PC Rose-John S Interleukin-6-type cytokines and their receptors for gene therapy of melanoma Ann N Y Acad Sci 1995, 762:361-373 7668537
34. Nawrocki S Mackiewicz A Genetically modified tumour vaccines - where we are today Cancer Treat Rev 1999, 25:29-46 10.1053/ctrv.1998.0104 10212588
35. Ullmann CD Schlom J Greiner JW Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells J Immunother 1992, 12:231-241 10.1097/00002371-199211000-00003 1477074
36. Dansky-Ullmann C Salgaller M Adams S Schlom J Greiner JW Synergistic effects of IL-6 and IFN-γ on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: Role for endogenous IFN-β Cytokine 1995, 7:118-129 10.1006/cyto.1995.1016 7780031
37. Hsiao Y-W Liao K-W Chung T-F Liu C-H Hsu C-D Chu R-M Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression Cancer Immunol Immunother 2008, 57:1091-1104 10.1007/s00262-007-0446-5 18259750
38. Eliopoulos AG Stack M Dawson CW Kaye KM Hodgkin L Sihota S Rowe M Young LS Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors Oncogene 1997, 14:2899-2916 10.1038/ sj.onc.1201258 9205097
39. Young LS Rickinson AB Epstein-Barr virus: 40 years on Nat Rev Cancer 2004, 4:757-768 10.1038/nrc1452 15510157
40. Lin C-T Dee A-N Chen W Chan W-Y Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines Lab Invest 1994, 71:731-736 7967524
41. Chantrain CF Feron O Marbaix E DeClerck YA Bone marrow microenvironment and tumor progression Cancer Microenvironment 2008, 1:23-25 2654350 19308682 10.1007/s12307-008-0010-7
42. Sohara Y Shimada H Minkin C Erdreich-Epstein A Nolta JA DeClerck YA Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells Cancer Res 2005, 65:1129-1135 10.1158/0008-5472.CAN-04-2853 15734993
43. Fierro FA Sierralta WD Epunan MJ Minguell JJ Marrow-derived mesenchymal stem cells: Role in epithelial tumor cell determination Clin Exp Metastasis 2004, 21:313-319 10.1023/B:CLIN.0000046130.79363.33 15554387
44. Ihle JN Witthuhn BA Quelle FW Yamamoto K Thierfelder WE Kreider B Silvennoinen O Signaling by the cytokine receptor superfamily: JAKs and STATs Trends Biochem Sci 1994, 19:222-227 10.1016/0968-0004(94)90026-4 8048164
45. Larner AC David M Feldman GM Igarashi K Hackett RH Webb DS Sweitzer SM Petricoin EF 3rd Finbloom DS Tyrosine phosphorylation of DNA binding proteins by multiple cytokines Science 1993, 261:1730-1733 10.1126/ science.8378773 8378773
46. Murakami M Hibi M Nakagawa N Nakagawa T Yasukawa K Yamanishi K Taga T Kishimoto T IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase Science 1993, 260:1808-1810 10.1126/ science.8511589 8511589
47. Faggioli L Merola M Hiscott J Furia A Monese R Tovey M Palmieri M Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-γ Eur J Immunol 1997, 27:3022-3030 10.1002/eji.1830271140 9394833
48. Gao SP Mark KG Leslie K Pao W Motoi N Gerald WL Travis WD Bornmann W Veach D Clarkson B et al Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas J Clin Invest 2007, 117:3846-3856 2096430 18060032 10.1172/JCI31871
49. Yeh H-H Lai W-W Chen H-H Liu H-S Su W-C Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 2006, 25:4300-4309 10.1038/ sj.onc.1209464 16518408